We are live on ! Find out more
WINT

Windtree Therapeutics
WINT

Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

6 hedge funds and large institutions have $3.33M invested in Windtree Therapeutics in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

17% less capital invested

Capital invested by funds: $4M → $3.33M (-$669K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
$2.31M
Puts
–
Net Calls
+$2.31M
Net Calls Change
+$2.31M

Top Buyers

Rank Fund Capital Flow
1
TI
tru Independence
Oregon
+$277K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$277K
2
PP
Paloma Partners
Connecticut
-$277K
3
Goldman Sachs
Goldman Sachs
New York
-$60K

WINT Hedge Fund Activity: Q4 2020 in Review

6 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics (WINT) for Q4 2020, worth a combined $3.33M — down 17% from $4M a quarter earlier.

Fund positioning in WINT was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was tru Independence, opening a new position worth an estimated $277K. The largest seller was Millennium Management, cutting an estimated $277K.

  • 6 institutional investors held Windtree Therapeutics (WINT) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $3.33M of Windtree Therapeutics stock for Q4 2020, down 17% quarter-over-quarter.
  • 1 fund opened new Windtree Therapeutics positions in Q4 2020 and 1 closed out, a net change of 0 holders.
  • The largest Windtree Therapeutics buyer in Q4 2020 was tru Independence, an estimated $277K added.
  • The largest Windtree Therapeutics seller in Q4 2020 was Millennium Management, an estimated $277K sold.

Based on aggregated 13F filings for Q4 2020.